Sarcopenia and blood myokine levels as prognostic biomarkers in patients with liver cirrhosis or hepatocellular carcinoma

키워드

참고문헌 (20)

1. Anand AC, "Nutrition and muscle in cirrhosis", J Clin Exp Hepatol, 7, pp.340~357 (2017)
2. Bosy-Westphal A, "Identification of skeletal muscle mass depletion across age and BMI groups in health and disease--there is need for a unified definition", Int J Obes(Lond), 39, pp.379~386 (2015)
3. 하연정, "Sarcopenia Predicts Prognosis in Patients with Newly Diagnosed Hepatocellular Carcinoma, Independent of Tumor Stage and Liver Function", Cancer Research and Treatment, 50(3), pp.843~851 (2018), 대한암학회
4. Romiti A, "Malabsorption and nutritional abnormalities in patients with liver cirrhosis", Ital J Gastroenterol, 22, pp.118~123 (1990)
5. Voron T, "Sarcopenia impacts on short-and long-term results of hepatectomy for hepatocellular carcinoma", Ann Surg, 261, pp.1173~1183 (2015)
6. Antonelli G, "Sarcopenia is associated with reduced survival in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment", United European Gastroenterol J, 6, pp.1039~1048 (2018)
7. Begini P, "Sarcopenia predicts reduced survival in patients with hepatocellular carcinoma at first diagnosis", Ann Hepatol, 16, pp.107~114 (2017)
8. Nishikawa H, "Prognostic significance of sarcopenia in patients with hepatocellular carcinoma undergoing sorafenib therapy", Oncol Lett, 14, pp.1637~1647 (2017)
9. Kanghyug Choi, "The association of the serum levels of myostatin, follistatin, and interleukin-6 with sarcopenia, and their impacts on survival in patients with hepatocellular carcinoma", Clinical and Molecular Hepatology, 26(4), pp.492~505 (2020), 대한간학회[DOI]
10. Pedersen BK, "Muscles, exercise and obesity : skeletal muscle as a secretory organ", Nat Rev Endocrinol, 8, pp.457~465 (2012)
11. Duggal NA, "Can physical activity ameliorate immunosenescence and thereby reduce age-related multi-morbidity?", Nat Rev Immunol, 19, pp.563~572 (2019)
12. Hung CH, "Insulin resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection", World J Gastroenterol, 16, pp.2265~2271 (2010)
13. Nishikawa H, "Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis", J Cachexia Sarcopenia Muscle, 8, pp.915~925 (2017)
14. Elkina Y, "The role of myostatin in muscle wasting : an overview", J Cachexia Sarcopenia Muscle, 2, pp.143~151 (2011)
15. Merli M, "MuRF-1 and p-GSK3β expression in muscle atrophy of cirrhosis", Liver Int, 33, pp.714~721 (2013)
16. Egerman MA, "Signaling pathways controlling skeletal muscle mass", Crit Rev Biochem Mol Biol, 49, pp.59~68 (2014)
17. Gonzalez-Cadavid NF, "Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting", Proc Natl Acad Sci U S A, 95, pp.14938~14943 (1998)
18. Hakvoort TB, "Pivotal role of glutamine synthetase in ammonia detoxification", Hepatology, 65, pp.281~293 (2017)
19. Rinnov AR, "Impaired follistatin secretion in cirrhosis", J Clin Endocrinol Metab, 101, pp.3395~3400 (2016)
20. Deli A, "Activins and activin antagonists in hepatocellular carcinoma", World J Gastroenterol, 14, pp.1699~1709 (2008)

관련 논문AI추천